Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, Yoshida H, Machinami R, Kishi K, Omata M
Second Department of Medicine, Faculty of Medicine, University of Tokyo, Japan.
Gastroenterology. 1996 Jan;110(1):227-31. doi: 10.1053/gast.1996.v110.pm8536861.
BACKGROUND & AIMS: We and others have previously shown that the mutation of K-ras codon 12 was found in the majority of pancreatic adenocarcinomas. The mutation has also been identified in the pancreatic duct with mucous cell hyperplasia in association with chronic pancreatitis. Ductal hyperplasia is also frequently found in the pancreas free from pancreatic carcinoma or chronic pancreatitis. The aim of this study was to assess the incidence and types of mutations in hyperplastic foci in these cases.
The nucleotide sequence of the K-ras gene at codon 12 of the DNA extracted from microdissected hyperplastic epithelium of the pancreatic duct obtained at autopsy in patients without pancreatic adenocarcinoma or chronic pancreatitis was analyzed.
Of 38 patients with 79 hyperplastic foci, 12 patients (with 19 hyperplastic foci) had mutations. None of the 16 normal ducts in 12 specimens had this mutation. The nucleotide sequence of the codon in 53% of ductal hyperplastic foci was TGT or AGT, both of which were not found in 30 cases of adenocarcinoma.
These results suggest that the ras gene mutation occurs frequently in multifocal hyperplastic foci of pancreatic duct and that the mutations may not have direct relevance to the carcinogenesis of pancreatic cancer.
我们和其他研究人员之前已经表明,在大多数胰腺腺癌中发现了K-ras密码子12的突变。在与慢性胰腺炎相关的伴有黏液细胞增生的胰腺导管中也发现了该突变。在无胰腺癌或慢性胰腺炎的胰腺中也经常发现导管增生。本研究的目的是评估这些病例中增生灶的突变发生率及类型。
对在尸检时获取的无胰腺癌或慢性胰腺炎患者的胰腺导管微切割增生上皮中提取的DNA的K-ras基因密码子12的核苷酸序列进行分析。
在38例有79个增生灶的患者中,12例患者(有19个增生灶)发生了突变。12个标本中的16条正常导管均无此突变。53%的导管增生灶密码子的核苷酸序列为TGT或AGT,在30例腺癌中均未发现这两种序列。
这些结果表明,ras基因突变在胰腺导管的多灶性增生灶中频繁发生,且这些突变可能与胰腺癌的发生没有直接关系。